Epitopes Required for Antibody‐Dependent Enhancement of Ebola Virus Infection
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2), S347-S356
- https://doi.org/10.1086/520581
Abstract
We have shown that antibody-dependent enhancement (ADE) of infection with Zaire Ebola virus (ZEBOV) is mediated by interaction of virus-specific antibodies with Fc receptors or complement component C1q and its receptors in vitro. ADE activities of the antisera to the viral glycoprotein (GP) were virus species specific and were primarily correlated with immunoglobulin (Ig) G2a and IgM levels but not with IgG1 levels. Interestingly, compared with ZEBOV, Reston Ebola virus (REBOV) had substantially weaker potential to induce ADE antibodies. Using monoclonal antibodies, we identified ZEBOV-specific ADE epitopes. To confirm epitope specificity, we constructed a chimeric ZEBOV GP, the ADE epitopes of which were replaced with the corresponding regions of REBOV GP. We found that mouse antisera to the chimeric ZEBOV GP showed less potential to induce ADE activity than did mouse antisera to wild-type ZEBOV GP, although they retained neutralizing activity. These data suggest that GP lacking the ADE-inducing epitopes may increase the potential of GP as a vaccine antigen.Keywords
This publication has 23 references indexed in Scilit:
- Protective efficacy of neutralizing antibodies against Ebola virus infectionVaccine, 2007
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesNature Medicine, 2005
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeysThe Lancet, 2003
- Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implicationsReviews in Medical Virology, 2003
- Antibody-Dependent Enhancement of Ebola Virus InfectionJournal of Virology, 2003
- Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis VirusesJournal of Virology, 2003
- Infectivity-Enhancing Antibodies to Ebola Virus GlycoproteinJournal of Virology, 2001
- C1q—how many functions? How many receptors?Trends in Cell Biology, 1998
- The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.Proceedings of the National Academy of Sciences of the United States of America, 1996
- GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases1Virology, 1995